Fundz

Actinogen Medical Appoints Andrew Udell as Chief Commercial Officer Reporting to CEO Dr Steven Gourlay

PRIVATEOct 29, 2024

Position

Chief Executive Officer

Company

Actinogen Medical

Steven Gourlay
steven.gourlay@actinogen.com.au
SydneyBiotechnologyHealth CareMedicalTherapeutics

Description

Actinogen Medical has announced the appointment of Andrew Udell, a US-based executive, as its chief commercial officer, reporting to CEO Dr Steven Gourlay. Mr Udell has extensive commercial experience in bringing CNS drugs to market.

Quick answer

Actinogen Medical Appoints Andrew Udell as Chief Commercial Officer Reporting to CEO Dr Steven Gourlay (October 29, 2024). Actinogen Medical is based in Sydney, New South Wales, Australia.

Who is the new Chief Executive Officer at Actinogen Medical?
Actinogen Medical named Steven Gourlay Chief Executive Officer, announced October 29, 2024.
What did Actinogen Medical announce on October 29, 2024?
Actinogen Medical has announced the appointment of Andrew Udell, a US-based executive, as its chief commercial officer, reporting to CEO Dr Steven Gourlay. Mr Udell has extensive commercial experience in bringing CNS drugs to market.
What does Actinogen Medical do?
Actinogen Medical is developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol.
Where is Actinogen Medical based?
Actinogen Medical is based in Sydney, New South Wales, Australia.
Which similar companies made leadership changes around the same time?
Parexel (October 22, 2024), Adverum Biotechnologies (October 17, 2024), Grey Wolf Therapeutics (November 14, 2024) and ALX Oncology (November 14, 2024) also announced leadership changes within 45 days of Actinogen Medical.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Actinogen Medical, and when

A new leader at Actinogen Medical brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Actinogen Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Actinogen Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Actinogen Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Actinogen Medical

Location

Sydney, New South Wales, Australia

About

Actinogen Medical is developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. It is currently developing its lead compound, Xanamem, as a potential new therapy for Alzheimer’s disease and depression.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Actinogen Medical changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Will
Likely contact at this company
••••••••@••••••••

See Will's verified email →

Andrew
Likely contact at this company
••••••••@••••••••

See Andrew's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Actinogen Medical's next move

Learn about Strategic plan

Actinogen Medical changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.